Home > PB Ratio > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
PB (Price/Book ) Ratio

The Current P/B Ratio of OXYGENTA PHARMACEUTICAL is -4.25.

Share Price ₹49.0Aug 04,2026
Market Cap ₹181.4 Cr
Book Value₹-42.7 CrMar2026 - Standalone Results
Price/Book -4.25xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of OXYGENTA PHARMACEUTICAL

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of OXYGENTA PHARMACEUTICAL is calculated as :

Current Market Cap [ ₹181.4 Cr] as on Aug 04,2026

(/) Book Value [ ₹-42.7 Cr] based on Mar2026 - Standalone Results

(=) P/B Ratio [ -4.25x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '-4.25 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of OXYGENTA PHARMACEUTICAL !

The chart below summarizes the trend in P/B Ratio of OXYGENTA PHARMACEUTICAL over the last five years.

Historical PB (Price/Book ) ratio chart of OXYGENTA PHARMACEUTICAL


PB Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL

- OXYGENTA PHARMACEUTICAL 's latest p/b ratio is -4.25x.

- OXYGENTA PHARMACEUTICAL 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged -4.50x.

- OXYGENTA PHARMACEUTICAL 's operated at median p/b ratio of -4.19x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/b ratio peaked in Mar2022 at -0.99x.

- OXYGENTA PHARMACEUTICAL 's p/b ratio hit its five-year low in Mar2025 of -11.48x.


How does OXYGENTA PHARMACEUTICAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
OXYGENTA PHARMACEUTICAL -42.69-4.25181.4
SUN PHARMACEUTICAL INDUSTRIES LTD83,570.105.63470,270.0
DIVIS LABORATORIES LTD16,761.0013.26222,224.0
TORRENT PHARMACEUTICALS LTD8,388.4322.81191,325.0
CIPLA LTD34,369.403.41117,139.0
DR REDDYS LABORATORIES LTD37,742.602.5796,876.6
MANKIND PHARMA LTD16,252.606.25101,638.0
LUPIN LTD22,384.104.85108,639.0
ZYDUS LIFESCIENCES LTD27,111.404.12111,571.0
AUROBINDO PHARMA LTD37,891.002.4191,128.4
LAURUS LABS LTD5,275.0818.8099,174.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs OXYGENTA PHARMACEUTICAL 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB -4.25x
Max industry PB 22.81x
Median industry PB 4.85x
Average industry PB 7.26x



You may also like the below Video Courses